PX1 Research provides synthetic, high-purity Chonluten (Glu-Asp-Gly) designed strictly for laboratory investigation into inflammatory signaling, mucosal tissue homeostasis, and cytokine regulation. Each lot undergoes rigorous third-party testing via RP-HPLC and mass spectrometry to confirm chemical identity, structural purity, and minimal endotoxin levels prior to dispatch.
PX1 Research provides synthetic, high-purity Chonluten (Glu-Asp-Gly) designed strictly for laboratory investigation into inflammatory signaling, mucosal tissue homeostasis, and cytokine regulation. Each lot undergoes rigorous third-party testing via RP-HPLC and mass spectrometry to confirm chemical identity, structural purity, and minimal endotoxin levels prior to dispatch.
Researchers seeking to buy peptide IL6 reduction Chonluten preparations for analytical assays require analytical-grade materials with fully verified purity profiles. Chonluten is a synthetic tripeptide composed of L-glutamic acid, L-aspartic acid, and glycine (H-Glu-Asp-Gly-OH). In preclinical literature, this bioregulatory sequence is investigated primarily for its capacity to modulate pro-inflammatory cytokine expression, specifically interleukin-6 (IL-6), within epithelial and respiratory tissue models.
When sourcing Chonluten for in vitro or animal models, laboratory performance depends on molecular integrity and batch uniformity. PX1 Research supplies laboratory-grade Chonluten manufactured under strict quality standards in US-based facilities. Every batch undergoes lot-specific testing to verify sequence accuracy and ensure absolute freedom from biological contaminants, providing empirical consistency across experimental replicates.
Chonluten, structurally designated as L-glutamyl-L-aspartyl-glycine (EDG), belongs to a specialized class of short regulatory peptides originally conceptualized to mimic endogenous tissue-specific signaling molecules. With a low molecular mass of approximately 305.24 g/mol, its simple peptide backbone allows for efficient cellular uptake and targeted interaction with nuclear chromatin and membrane-bound receptor complexes in experimental setups.
The short chain length minimizes steric hindrance, facilitating physical interactions with specific promoter regions of DNA in laboratory cell cultures. Researchers examining the broad library of all peptides often utilize short tripeptides like Chonluten because their defined chemistry provides predictable solubility, high stability in aqueous buffers, and clear analytical resolution during high-performance liquid chromatography (HPLC) screening.
Interleukin-6 (IL-6) acts as a pivotal pro-inflammatory cytokine secreted during acute and chronic cellular stress. Elevated local and systemic IL-6 levels trigger downstream signaling cascades via the JAK-STAT pathway, promoting hyper-inflammatory states, tissue degradation, and cellular senescence. In vitro research demonstrates that exposure to Chonluten alters the transcription kinetics of genes encoding pro-inflammatory mediators, leading to a measurable reduction in IL-6 gene expression and protein secretion.
Preclinical models evaluating pulmonary macrophages and bronchial epithelial cell lines indicate that Chonluten normalizes nuclear factor kappa B (NF-κB) activation under lipopolysaccharide (LPS) challenge. By attenuating the hyper-activation of NF-κB, Chonluten effectively down-regulates transcript levels for IL-6, TNF-alpha, and IL-1 beta. Investigators focused on interleukin-6 signaling peptides study these mechanisms to quantify how low-molecular-weight bioregulators restore homeostatic baseline values in damaged tissue explants without compromising broader cellular viability.
The primary focus of empirical literature involving Chonluten centers on bronchial and alveolar tissue protection under oxidative or environmental stress. Rodent models exposed to acute respiratory stressors exhibit marked inflammatory infiltration and structural remodeling of airway walls. Preclinical administration of Chonluten in these models has demonstrated a decrease in inflammatory cell recruitment, reduced alveolar wall thickening, and decreased local concentrations of IL-6 within bronchoalveolar lavage fluid (BALF).
Furthermore, cell culture assays involving human bronchial epithelial cells demonstrate that Chonluten up-regulates protein synthesis associated with mucosal repair and surfactant homeostasis. By mitigating local IL-6 production, the peptide helps preserve cell-cell tight junctions and transmembrane electrical resistance in cultured monolayers. These findings make Chonluten a target for studies exploring chronic airway inflammation, fibrotic responses, and epithelial barrier recovery.
To contextualize the signaling profile of Chonluten, researchers frequently contrast its actions with other short-chain bioregulators and repair-focused compounds. While Chonluten specifically targets bronchial epithelial signaling and IL-6 down-regulation, related compounds operate through distinct molecular targets. For instance, Epitalon (Ala-Glu-Asp-Gly) is a tetrapeptide evaluated predominantly for telomerase activation and neuroendocrine regulation, whereas KPV (Lys-Pro-Val) exerts potent anti-inflammatory effects through direct nuclear translocation without tissue-specific restriction.
Similarly, broad-spectrum tissue repair compounds such as BPC-157 target angiogenic pathways and nitric oxide synthases to accelerate wound healing across mucosal and musculoskeletal models. Unlike broader signaling molecules, Chonluten displays a specialized affinity for pulmonary transcriptional pathways, making it a unique tool when the objective is targeted modulation of localized respiratory inflammatory cascades. Laboratory groups frequently source these complementary agents via wholesale lab accounts to execute multi-target cytokine screening panels.
Chonluten is supplied as a sterile, lyophilized white powder to maximize chemical stability during transport and storage. For laboratory experimentation, standard reconstitution involves dissolving the lyophilized cake in sterile Bacteriostatic Water, Phosphate-Buffered Saline (PBS, pH 7.4), or endotoxin-free water depending on experimental requirements. Due to its hydrophilic polar side chains, the tripeptide dissolves rapidly without requiring organic co-solvents or aggressive vortexing.
When preparing stock solutions for cell culture or enzymatic assays, technicians should perform initial reconstitution inside a certified laminar flow hood to maintain sterility. Gentle inversion or mild swirly motion is recommended to achieve complete dissolution. For detailed procedures regarding volumetric calculations, concentration stock preservation, and carrier protein additions, consult our laboratory peptide reconstitution guide.
In its lyophilized state, Chonluten exhibits high thermodynamic stability. Unopened vials should be stored at -20°C for long-term preservation, protected from light and moisture exposure. Standard storage under these controlled conditions prevents peptide bond hydrolysis and racemization over extended periods.
Once reconstituted into aqueous solutions, liquid aliquots should be used immediately or divided into single-use experimental volumes and stored at -80°C to avoid repeated freeze-thaw cycles. Freeze-thaw cycling introduces structural stresses that can alter physical concentration or induce peptide aggregation. Reconstituted solutions kept at 4°C are generally stable for short-term use (typically up to 7–14 days in buffered media), provided non-pyrogenic, sterile containers are used throughout.
The validity of preclinical cytokine research depends entirely on the analytical purity of the test compound. Traces of residual solvents, truncated peptide sequences, or bacterial endotoxins can confound cytokine assays, producing false-positive inflammatory spikes in cell culture models. Therefore, evaluating suppliers requires demanding complete analytical transparency before purchasing.
PX1 Research enforces strict quality control standards for every production lot. Each batch of Chonluten undergoes dual validation via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to verify chromatographic purity exceeds 98.0%, and Electrospray Ionization Mass Spectrometry (ESI-MS) to confirm exact molecular mass (305.24 Da). Additionally, chromogenic LAL assays ensure bacterial endotoxin levels remain strictly under <0.01 EU/mg, preventing background cytokine activation during delicate in vitro experiments. Researchers can inspect these metrics directly within our open-access PX1 research library.
When placing orders to buy peptide IL6 reduction Chonluten reagents, academic, industrial, and clinical research institutions require fast, traceable supply chain logistics. PX1 Research fulfills orders directly from state-of-the-art facilities located in California and Arizona, ensuring rapid order handling and strict climate-controlled storage until shipment.
All orders processed Monday through Friday are dispatched same-day to minimize transit times and mitigate exposure to elevated ambient temperatures. PX1 Research delivers fully documented, USA-manufactured research peptides designed to provide absolute consistency, batch-to-batch repeatability, and uncompromised structural integrity for high-impact laboratory investigation.
What is the primary mechanism of Chonluten regarding IL-6 reduction in research?
Preclinical studies show that Chonluten (Glu-Asp-Gly) interacts with nuclear chromatin to modulate NF-κB transcription factor activity. Under inflammatory stress, this down-regulates transcript expression and protein secretion of pro-inflammatory cytokines, specifically interleukin-6 (IL-6), in bronchial epithelial cells and tissue explants.
How does PX1 Research verify the purity of Chonluten?
Every lot of Chonluten undergoes independent third-party analytical testing, including Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity assessment (guaranteed >98%) and Mass Spectrometry (MS) for exact mass verification. Certificates of Analysis (COAs) are published per lot.
What are the endotoxin limits for PX1 Research peptides?
PX1 Research subjects all peptides to rigorous chromogenic LAL testing to ensure endotoxin levels measure under <0.01 EU/mg. This low endotoxin threshold prevents false-positive inflammatory signals during cellular and in vitro assays.
How should lyophilized Chonluten be stored upon delivery?
Lyophilized Chonluten should be stored in a freezer at -20°C for long-term stability. The vial should be kept sealed and protected from light and ambient humidity until reconstitution.
What diluent is recommended for reconstituting Chonluten for laboratory assays?
Chonluten is readily soluble in standard laboratory diluents including sterile Bacteriostatic Water, sterile normal saline, or Phosphate-Buffered Saline (PBS, pH 7.4), depending on the requirements of your specific in vitro or cell culture protocol.
Can reconstituted Chonluten be repeatedly frozen and thawed?
Repeated freeze-thaw cycles should be strictly avoided as they can degrade peptide integrity. It is recommended to aliquot reconstituted stock solutions into single-use working volumes prior to storing at -80°C.
Is Chonluten identical to Epitalon or other short bioregulatory peptides?
No. While both belong to the short-chain bioregulatory peptide family, Chonluten is a tripeptide (Glu-Asp-Gly) primarily studied for respiratory mucosal and IL-6 cytokine pathways. Epitalon is a tetrapeptide (Ala-Glu-Asp-Gly) studied predominantly for telomerase and pineal gland activity.
Are PX1 Research compounds intended for human use or clinical therapy?
No. All products sold by PX1 Research, including Chonluten, are strictly intended for laboratory research use only (RUO), including in vitro assays and preclinical animal models. They are not for human consumption, clinical diagnosis, or therapeutic use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.